Stephan Toutain and Mary Hiter
Interleukin Genetics has appointed Stephan Toutain as chief commercial officer and Mary Hiter as director of marketing. Toutain joins Interleukin Genetics following three years as a marketing and market access consultant to the biopharmaceutical industry. He previously headed global commercial development for Sarepta Therapeutics and served as general manager for Alexion in Europe. Hiter joins Interleukin Genetics from Abbott Point of Care, where she served for eight years as director of marketing. Prior to Abbott, she held various marketing and product management roles with Cybertronics (now LivaNova), Watson Pharmaceuticals, and Knoll Pharmaceuticals.